Articles From: Stemline Therapeutics In-Licenses Novel Oral Small Molecule Nuclear Transport Inhibitor Targeting XPO1 to Gluskin Sheff + Associates Inc. Second Quarter Fiscal 2015 Results and Conference Call Schedule


American Eagle Outfitters, Inc. (NYSE:AEO) today announced that management will present at the 17th Annual ICR XChange Conference on Monday, January 12, 2015 at 10:30 AM EST.
Sign-up for American Eagle Outfitters to Present at the 17th Annual ICR XChange Conference investment picks
U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of physical therapy outpatient clinics (the “Company”), today announced that its Chief Executive Officer, Chris Reading, will present at the Sidoti & Company, LLC Emerging Growth Institutional Investor Forum on Monday, January 12, 2015.
Sign-up for U.S. Physical Therapy to Present at the Sidoti & Company, LLC Emerging Growth Institutional Investor Forum investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167968&ProfileId=051205&sourceType=1 LYNNWOOD, WA --
Sign-up for Zumiez Inc. Reports December 2014 Sales Results investment picks
Mandalay Resources Corporation Announces Changes to its Management Team Canada NewsWire TORONTO , Jan.
Sign-up for Mandalay Resources Corporation Announces Changes to its Management Team investment picks
Resources Connection, Inc. (NASDAQ: RECN), today announced financial results for its fiscal second quarter ended November 29, 2014.
Sign-up for Resources Connection, Inc. Reports Second Quarter Results for Fiscal 2015 investment picks
http://media.marketwire.com/attachments/201007/619021_LogoPerceptronHiResNoTag.PNG.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168009&ProfileId=051205&sourceType=1 PLYMOUTH, MI --
Sign-up for Perceptron to Attend Investor Conferences in New York the Week of January 12, 2015; Needham Growth Conference Presentation to Be Webcast on January 13, 2015 investment picks
2015/1/7
HONOLULU , Jan.
Sign-up for Hawaiian Airlines Sets New Record Carrying 10.2 Million Passengers in 2014 investment picks
LONG BEACH, N.Y., Jan.
Sign-up for Planet Payment Appoints Charles J. Giglia as CIO investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced its 2015 strategic overview and enrollment of the first patient expressing a KRAS mutation in a global, multicenter two-tiered phase 2 trial with BIND-014 in non-small cell lung cancer (NSCLC) patients with KRAS mutant tumors (mutated Kirsten ras oncogene homolog) or squamous histology.
Sign-up for BIND Therapeutics Provides Clinical Update for BIND-014 and 2015 Strategic Overview investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G029661-001&sourceType=1 http://www.marketwire.com/library/MwGo/2015/1/6/11G029661/Biodel-Life-Delivered_000-1401197537254-220269572145.jpg DANBURY, CT--(Marketwired - January 07, 2015) - Biodel Inc. (NASDAQ: BIOD) announced positive preliminary results from Study 3-151, a Phase 2a clinical trial comparing Biodel's proprietary, concentrated insulin formulation BIOD-531 to Humalog ® Mix 75/25 and Humulin ® R U-500 in patients with type 1 and type 2 diabetes with severe insulin resistance who use at least 150 units of insulin per day or at least 100 units of insulin in a single injection.
Sign-up for Biodel's Concentrated Insulin BIOD-531 Demonstrates Superior Post-Meal Glucose Control Compared to Marketed Prandial/Basal Insulins in Patients With Diabetes Who Require High Doses of Insulin investment picks
BRIDGEHAMPTON, N.Y., Jan.
Sign-up for Bridge Bancorp, Inc. Announces Fourth Quarter 2014 Dividend investment picks
2015/1/7
By Jennifer Booton, MarketWatch Virtuix, Samsung ready for an explosion of at-home virtual reality Virtual reality is known for bulky goggles and starring roles in science fiction films.
Sign-up for UPDATE: At CES, virtual reality gets ready to invade your home investment picks
2015/1/7
NORFOLK, Va.
Sign-up for Norfolk Southern facilitates $5.7 billion in industrial investment along rail lines in 2014 investment picks
Levi & Korsinsky is investigating the Board of Directors of State Investors Bancorp, Inc. (“State Investors” or “the Company”) (NASDAQ:SIBC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to First NBC Bank Holding Company.
Sign-up for SIBC SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches an Investigation of the Board of Directors of State Investors Bancorp, Inc. Regarding the Fairness of the Sale of the Company to First NBC Bank Holding Company investment picks
2015/1/7
NEW YORK , Jan.
Sign-up for CBS Corporation Announces $1.2 Billion Senior Notes Offering investment picks
2015/1/7
Laurentian Bank's President and Chief Executive Officer to Take Part in RBC Capital Markets' Canadian Bank CEO Conference Canada NewsWire MONTRÉAL, Jan.
Sign-up for Laurentian Bank's President and Chief Executive Officer to Take Part in RBC Capital Markets' Canadian Bank CEO Conference investment picks
ORLANDO, Fla.
Sign-up for Tupperware Brands Corporation Announces Upcoming Webcast investment picks
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of InvenSense, Inc. (“InvenSense” or the “Company”) (NYSE:INVN) concerning possible violations of federal securities laws.
Sign-up for INVESTOR ALERT: Investigation of InvenSense, Inc. Announced by Glancy Binkow & Goldberg LLP investment picks
TROY, Mich.
Sign-up for Flagstar Announces Fourth Quarter 2014 Earnings Call investment picks
2015/1/7
Lowe's Iris products joining Icontrol's OpenHome™ ecosystem of connected products; Lowe's to feature OpenHome brand in stores to guide shoppers looking for customizable smart homes REDWOOD CITY, Calif.
Sign-up for Icontrol Networks and Lowe's to Offer Customers More Smart Home Options investment picks
2015/1/7
By Anora Mahmudova and Sara Sjolin, MarketWatch J.C. Penney surges as holiday sales top expectations NEW YORK (MarketWatch) -- U.S. stocks rebounded on Wednesday, placing the S&P 500 on pace to break a five-day losing streak while the index tried to claw back some of the hefty losses in the wake of two days of blistering selling.
Sign-up for UPDATE: S&P 500 on track to snap 5-day losing streak investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0986682001&sourceType=1 http://media3.marketwire.com/logos/20130528-aab0528.jpg TORONTO, ONTARIO --
Sign-up for Aberdeen Files Information Circular Outlining Plan for Value Creation and Exposing Dissident Self-Interest investment picks
2015/1/7
By Saumya Vaishampayan U.S. stocks remained higher Wednesday after the release of minutes from the Federal Reserve's latest meeting, with the S&P 500 on track to snap a five-session losing streak.
Sign-up for U.S. Stocks Stay Higher After Fed Minutes investment picks
2015/1/7
Iris Coldibelli and Charlie Quirk Join Team as Global Strategy Directors DETROIT , Jan.
Sign-up for Commonwealth//McCann Announces Jonathan Disegi as EVP, Global Director of Strategy and Research investment picks
2015/1/7
NEW YORK , Jan.
Sign-up for XL Group Expands Insurance Distribution & Network Team, Adding June H. Dwyer as Northeast Leader investment picks
2015/1/7
Gluskin Sheff + Associates Inc. Second Quarter Fiscal 2015 Results and Conference Call Schedule Canada NewsWire TORONTO , Jan.
Sign-up for Gluskin Sheff + Associates Inc. Second Quarter Fiscal 2015 Results and Conference Call Schedule investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Stemline Therapeutics In-Licenses Novel Oral Small Molecule Nuclear Transport Inhibitor Targeting XPO1 to Gluskin Sheff + Associates Inc. Second Quarter Fiscal 2015 Results and Conference Call Schedule
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent